Biotech entity
CMS Laser is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. Across a 10-day span, the pace is roughly 1.4 stories per week. The clearest coverage concentration is fda-approval: 1 of 2 stories, with the rest divided among 1 other category.
Last mentioned: 8h ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
CMS Laser is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. Across a 10-day span, the pace is roughly 1.4 stories per week. The clearest coverage concentration is fda-approval: 1 of 2 stories, with the rest divided among 1 other category. They are better corroborated than the beat average, carrying 2.5 original sources each against 2.2 for the same window. Their average consequence score of 5 runs below the beat's 5.7 for that window. This profile follows 2 Biotech stories mentioning Laser Photonics Corporation across the period from August 15, 2026 to August 24, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 37 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Laser Photonics Corporation. Shared-story counts are live from our verified record — not editorial picks.
Q2 2026 financial results reported
Laser Photonics reports net sales of $1.8 million and positive gross margin; Zeo reports 23% sequential revenue growth; Clene reports Q2 results and CNM-Au8 program updates.
Q2 2026 reporting period ends
Laser Photonics, Zeo Energy, and Clene complete the second quarter ended June 30, 2026.
FDA meeting minutes confirm accelerated approval pathway for CNM-Au8
Clene receives formal meeting minutes stating its proposed NfL data may be capable of supporting an NDA for CNM-Au8 in ALS under accelerated approval.
A U.S. pharma manufacturer has ordered a complete TD-70 laser tablet drilling line from Laser Photonics' CMS Laser for $1.05M, adding 70,000-tablet/hour capacity for controlled-release dosage manufacturing with full IQ/OQ/PQ validation.
Source: hawaiitelegraph.com · pr-inside.com
Clene Inc. reports FDA meeting minutes confirm an accelerated approval pathway for CNM-Au8 in ALS. New biomarker analyses link NfL stabilization to longer survival and improved function. The company plans to submit an NDA, citing data from two completed Phase 2 trials.
Source: californiatelegraph.com · hawaiitelegraph.com
Laser Photonics Corporation is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
